Literature DB >> 20413676

A real-time PCR assay for the simultaneous detection of functional N284I and L412F polymorphisms in the human Toll-like receptor 3 gene.

Robert A Brown1, Raymund R Razonable.   

Abstract

Toll-like receptors (TLR) serve important roles in immunity against microbial pathogens, and TLR3 plays a critical role in the recognition of double-stranded RNA derived from viruses. Two specific single nucleotide polymorphisms (SNP) in the human TLR3 gene, A851T and C1234T, which result in amino acid substitutions, N284I and L412F, respectively, have been described to result in impaired receptor signaling and function in an in vitro model. Hence, an assay that could simultaneously detect these two functional TLR3 SNPs could facilitate studies into their role in the pathogenesis of human viral diseases and serve as a tool to screen viral disease predisposition. Therefore, we developed a real-time PCR assay based on a LightCycler format for simultaneous detection of A851T and C1234T SNPs within the TLR3 gene. This relatively low-cost PCR assay is proposed as a novel tool in the study of TLR3 and its role in viral disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20413676      PMCID: PMC2893634          DOI: 10.2353/jmoldx.2010.090122

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  14 in total

1.  Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the Toll-like receptor -2, -4, and -9 genes.

Authors:  Lutz Hamann; Axel Hamprecht; Abuzeid Gomma; Ralf R Schumann
Journal:  J Immunol Methods       Date:  2004-02-15       Impact factor: 2.303

2.  Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection.

Authors:  John West; Blossom Damania
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

3.  Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells.

Authors:  C T Ranjith-Kumar; William Miller; Jingchuan Sun; Jin Xiong; Jon Santos; Ian Yarbrough; Roberta J Lamb; Juliane Mills; Karen E Duffy; Scott Hoose; Mark Cunningham; Andreas Holzenburg; M Lamine Mbow; Robert T Sarisky; C Cheng Kao
Journal:  J Biol Chem       Date:  2007-04-13       Impact factor: 5.157

4.  Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes.

Authors:  F J Pirie; R Pegoraro; A A Motala; S Rauff; L Rom; T Govender; T M Esterhuizen
Journal:  Tissue Antigens       Date:  2005-08

5.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

6.  Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly.

Authors:  Kok-Fai Kong; Karine Delroux; Xiaomei Wang; Feng Qian; Alvaro Arjona; Stephen E Malawista; Erol Fikrig; Ruth R Montgomery
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

7.  Rhinovirus-induced major airway mucin production involves a novel TLR3-EGFR-dependent pathway.

Authors:  Lingxiang Zhu; Pak-Kei Lee; Wai-Ming Lee; Yuhua Zhao; Dongfang Yu; Yin Chen
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-31       Impact factor: 6.914

8.  Toll-like receptor 3 has a protective role against West Nile virus infection.

Authors:  Stephane Daffis; Melanie A Samuel; Mehul S Suthar; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

9.  Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection.

Authors:  M C Villacres; O Literat; M DeGiacomo; W Du; T Frederick; A Kovacs
Journal:  J Viral Hepat       Date:  2008-02       Impact factor: 3.728

10.  TLR3 deficiency in patients with herpes simplex encephalitis.

Authors:  Shen-Ying Zhang; Emmanuelle Jouanguy; Sophie Ugolini; Asma Smahi; Gaëlle Elain; Pedro Romero; David Segal; Vanessa Sancho-Shimizu; Lazaro Lorenzo; Anne Puel; Capucine Picard; Ariane Chapgier; Sabine Plancoulaine; Matthias Titeux; Céline Cognet; Horst von Bernuth; Cheng-Lung Ku; Armanda Casrouge; Xin-Xin Zhang; Luis Barreiro; Joshua Leonard; Claire Hamilton; Pierre Lebon; Bénédicte Héron; Louis Vallée; Lluis Quintana-Murci; Alain Hovnanian; Flore Rozenberg; Eric Vivier; Frédéric Geissmann; Marc Tardieu; Laurent Abel; Jean-Laurent Casanova
Journal:  Science       Date:  2007-09-14       Impact factor: 47.728

View more
  1 in total

1.  TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR+ head and neck cancer cells.

Authors:  Chwee Ming Lim; Ryan Stephenson; Andres M Salazar; Robert L Ferris
Journal:  Oncoimmunology       Date:  2013-04-29       Impact factor: 8.110

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.